Evidence map›Paper›PMID 19578118›Full record

ArticleThe Journal of biological chemistry2009

Sac3 is an insulin-regulated phosphatidylinositol 3,5-bisphosphate phosphatase: gain in insulin responsiveness through Sac3 down-regulation in adipocytes.

Ognian C Ikonomov, Diego Sbrissa, Takeshi Ijuin, Tadaomi Takenawa, Assia Shisheva

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. PI5P and PI(3,5)PCell structure and function · 2017
    Review
  6. Article
  7. Phosphoinositides: Key modulators of energy metabolism.Biochimica et biophysica acta · 2015
    Review
  8. Article
  9. Reactivation of Lysosomal Ca2+ Efflux Rescues Abnormal Lysosomal Storage in FIG4-Deficient Cells.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Ognian C IkonomovDepartment of Physiology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Diego Sbrissa
Takeshi Ijuin
Tadaomi Takenawa
Assia Shisheva
Wayne State University · USKobe University · JP

Funding

FUNCTIONS OF ADIPOCYTE PIKFYVE AND ITS LIPID PRODUCTSR01DK058058 · NIDDK · WAYNE STATE UNIVERSITY · PI SHISHEVA, ASSIA · 2002 to 2011
$2.8M
NIDDK NIH HHS DK58058NIDDK NIH HHS R01 DK058058
6 · The paper itself

Abstract

Insulin-regulated stimulation of glucose entry and mobilization of fat/muscle-specific glucose transporter GLUT4 onto the cell surface require the phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P(2)) pathway for optimal performance. The reduced insulin responsiveness observed under ablation of the PtdIns(3,5)P(2)-synthesizing PIKfyve and its associated activator ArPIKfyve in 3T3L1 adipocytes suggests that dysfunction of the PtdIns(3,5)P(2)-specific phosphatase Sac3 may yield the opposite effect. Paradoxically, as uncovered recently, in addition to turnover Sac3 also supports PtdIns(3,5)P(2) biosynthesis by allowing optimal PIKfyve-ArPIKfyve association. These opposing inputs raise the key question as to whether reduced Sac3 protein levels and/or hydrolyzing activity will produce gain in insulin responsiveness. Here we report that small interfering RNA-mediated knockdown of endogenous Sac3 by approximately 60%, which resulted in a slight but significant elevation of PtdIns(3,5)P(2) in 3T3L1 adipocytes, increased GLUT4 translocation and glucose entry in response to insulin. In contrast, ectopic expression of Sac3(WT), but not phosphatase-deficient Sac3(D488A), reduced GLUT4 surface abundance in the presence of insulin. Endogenous Sac3 physically assembled with PIKfyve and ArPIKfyve in both membrane and soluble fractions of 3T3L1 adipocytes, but this remained insulin-insensitive. Importantly, acute insulin markedly reduced the in vitro C8-PtdIns(3,5)P(2) hydrolyzing activity of Sac3. The insulin-sensitive Sac3 pool likely controls a discrete PtdIns(3,5)P(2) subfraction as the high pressure liquid chromatography-measurable insulin-dependent elevation in total [(3)H]inositol-PtdIns(3,5)P(2) was minor. Together, our data identify Sac3 as an insulin-sensitive phosphatase whose down-regulation increases insulin responsiveness, thus implicating Sac3 as a novel drug target in insulin resistance.

Indexed as

Insulin Resistance3T3-L1 CellsAdipocytesAnimalsDNA-Binding ProteinsEnzyme ActivationGlucoseHypoglycemic AgentsInsulinMicePhosphatidylinositol PhosphatesPhosphoric Monoester HydrolasesRNA, Small InterferingTranscription FactorsDNA-Binding ProteinsGlucoseGLUT4 enhancer factor, mouseHypoglycemic AgentsInsulinphosphatidylinositol 3,5-diphosphatePhosphatidylinositol PhosphatesPhosphoric Monoester HydrolasesRNA, Small InterferingTranscription Factors

Identifiers

PMID19578118
PMCPMC2781990
OpenAlexW2096586300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.